Tonix Pharmaceuticals Holding Corp (TNXP)

Überblick Nachrichten Preisverlauf Financials Warum fällt TNXP? Forum Prognose Aktiensplit

Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	64.66% 3.29	1.998	2.429	2.582	2.822
Cost Of Revenue	58.22% 1.367	3.272	0.943	1.183	1.555
Gross Profit	250.94% 1.923	-1.274	1.486	1.399	1.267
Operating Expenses	29.49% 34.99	27.02	17.54	23.88	16.82
Benefits Costs and Expenses	20.01% 36.36	30.29	18.48	25.06	18.38
Costs And Expenses	20.01% 36.36	30.29	18.48	25.06	18.38
Depreciation and Amortization	20.00% 0.40	0.50	0.50	0.50	0.50
Operating Income/Loss	16.86% -33.07	-28.30	-16.05	-22.48	-15.55
Income/Loss From Continuing Operations Before Tax	16.96% -33.07	-28.27	-16.83	-22.48	-15.55
Income/Loss From Continuing Operations After Tax	13.22% -32.01	-28.27	-16.83	-22.11	-14.21
Net Income/Loss	13.22% -32.01	-28.27	-16.83	-22.11	-14.21
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	21.78% 8.9228	7.3273	5.9272	-22.40	62.12
Diluted Average Shares	21.78% 8.9228	7.3273	5.9272	-22.40	62.12
Basic Earnings Per Share	6.99% -3.59	-3.86	-2.84	-171.94	-0.23
Diluted Earnings Per Share	6.99% -3.59	-3.86	-2.84	-171.94	-0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%